| 2901 |
Bone Marrow |
Allogeneic |
Infant Acute Lymphoblastic Leukemia With Kmt2a Gene Rearrangement |
Hematology |
2022 |
Standard Therapy |
Poland |
7 months |
| 2902 |
Bone Marrow |
Allogeneic |
Juvenile Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2903 |
Bone Marrow |
Allogeneic |
Juvenile Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2904 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
49 |
| 2905 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
16 |
| 2906 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
63 |
| 2907 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 2908 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
14 |
| 2909 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
15 |
| 2910 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
51 |
| 2911 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
8 |
| 2912 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
12 |
| 2913 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
65 |
| 2914 |
Bone Marrow |
Allogeneic |
Myelofibrosis |
Hematology |
2022 |
Standard Therapy |
Poland |
56 |
| 2915 |
Bone Marrow |
Allogeneic |
Myelofibrosis |
Hematology |
2022 |
Standard Therapy |
Poland |
17 |
| 2916 |
Bone Marrow |
Allogeneic |
Nhl (Non-Hodgkin's Lymphoma) |
Hematology |
2022 |
Standard Therapy |
Poland |
37 |
| 2917 |
Bone Marrow |
Allogeneic |
Nijmegen Breakage Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
9 |
| 2918 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2022 |
Standard Therapy |
Poland |
13 |
| 2919 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2920 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 2921 |
Bone Marrow |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
53 |
| 2922 |
Bone Marrow |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
37 |
| 2923 |
Bone Marrow |
Allogeneic |
Osteopetrosis |
Hematology |
2022 |
Standard Therapy |
Poland |
2 |
| 2924 |
Bone Marrow |
Allogeneic |
Other Immune System Disorders |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2925 |
Bone Marrow |
Allogeneic |
Other Non-Malignant Disease |
Hematology |
2022 |
Standard Therapy |
Poland |
8 |
| 2926 |
Bone Marrow |
Allogeneic |
Paroxysmal Nocturnal Hemoglobinuria (Pnh) |
Hematology |
2022 |
Standard Therapy |
Poland |
17 |
| 2927 |
Bone Marrow |
Allogeneic |
Paroxysmal Nocturnal Hemoglobinuria With Marrow Failure |
Hematology |
2022 |
Standard Therapy |
Poland |
10 |
| 2928 |
Bone Marrow |
Allogeneic |
Philadelphia-Positive Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2929 |
Bone Marrow |
Allogeneic |
Pre-B Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
32 |
| 2930 |
Bone Marrow |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 2931 |
Bone Marrow |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
9 months |
| 2932 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
46 |
| 2933 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
6 |
| 2934 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
15 |
| 2935 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
65 |
| 2936 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
12 |
| 2937 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2938 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
15 |
| 2939 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2940 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2941 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
19 |
| 2942 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
6 |
| 2943 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2944 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
35 |
| 2945 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2946 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
5 |
| 2947 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
30 |
| 2948 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
14 |
| 2949 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
49 |
| 2950 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
3 months |
| 2951 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
2 months |
| 2952 |
Bone Marrow |
Allogeneic |
Shwachman-Diamond Syndrome – Sds |
Hematology |
2022 |
Standard Therapy |
Poland |
7 |
| 2953 |
Bone Marrow |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2954 |
Bone Marrow |
Allogeneic |
Very Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
16 |
| 2955 |
Bone Marrow |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2956 |
Bone Marrow |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 2957 |
Bone Marrow |
Allogeneic |
X-Linked Congenital Dyskeratosis |
Hematology |
2022 |
Standard Therapy |
Poland |
2 |
| 2958 |
Apheresis |
Allogeneic |
Acute Biphenotypic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
22 |
| 2959 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
41 |
| 2960 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
55 |
| 2961 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
4 |
| 2962 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
29 |
| 2963 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
59 |
| 2964 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
9 |
| 2965 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
57 |
| 2966 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
24 |
| 2967 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
36 |
| 2968 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
24 |
| 2969 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
47 |
| 2970 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
25 |
| 2971 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
29 |
| 2972 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
7 |
| 2973 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
13 |
| 2974 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
7 |
| 2975 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
8 |
| 2976 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2977 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
35 |
| 2978 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
67 |
| 2979 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
69 |
| 2980 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
65 |
| 2981 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
10 |
| 2982 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
49 |
| 2983 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
75 |
| 2984 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
57 |
| 2985 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
14 |
| 2986 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
58 |
| 2987 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
54 |
| 2988 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
58 |
| 2989 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
29 |
| 2990 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
36 |
| 2991 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
57 |
| 2992 |
Apheresis |
Allogeneic |
Acute Myelofibrosis |
Hematology |
2022 |
Standard Therapy |
Poland |
55 |
| 2993 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
69 |
| 2994 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
39 |
| 2995 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
62 |
| 2996 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
69 |
| 2997 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
30 |
| 2998 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
60 |
| 2999 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
74 |
| 3000 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
45 |